Half-Life of Bupropion (Wellbutrin)
The mean elimination half-life of bupropion is 21 (±9) hours, as indicated in the FDA drug label. 1
Pharmacokinetic Profile of Bupropion
Bupropion undergoes extensive metabolism in the body, resulting in three active metabolites with their own half-lives:
- Parent drug (bupropion): 21 (±9) hours 1
- Hydroxybupropion (primary active metabolite): approximately 20 (±5) hours 1
- Threohydrobupropion: approximately 37 (±13) hours 1
- Erythrohydrobupropion: approximately 33 (±10) hours 1
Metabolite Activity and Concentrations
The metabolites of bupropion contribute significantly to its clinical effects:
- Hydroxybupropion is approximately 50% as potent as bupropion, but its plasma concentration at steady state is about 7 times higher than the parent drug 1
- Threohydrobupropion and erythrohydrobupropion are about 5-fold less potent than bupropion 1
- At steady state, the AUC (area under the curve) of hydroxybupropion is approximately 13 times that of bupropion 1
Formulation Differences
The pharmacokinetic profile varies slightly between different formulations of bupropion:
- Immediate Release (IR): Peak plasma concentration reached in approximately 1.5 hours 2
- Sustained Release (SR): Peak plasma concentration reached in approximately 3 hours 2
- Extended Release (XL): Peak plasma concentration reached in approximately 5 hours 2
Despite these differences in absorption rates, all three formulations are bioequivalent in terms of overall drug exposure 2.
Clinical Implications
The relatively long half-life of bupropion and its metabolites has important clinical implications:
- Allows for once-daily dosing with the XL formulation 3
- Steady-state plasma concentrations are typically reached within 8 days of starting treatment 1
- The extended half-life of the metabolites means they accumulate to higher concentrations than the parent drug during chronic dosing 1
- When discontinuing bupropion, a gradual tapering approach is recommended to minimize withdrawal symptoms 3
Factors Affecting Half-Life
Several factors can influence the half-life and metabolism of bupropion:
- Hepatic impairment: May prolong half-life and increase drug exposure 3
- Renal impairment: Requires dose adjustment, with half the normal dose recommended for moderate to severe renal impairment 3
- Drug interactions: Medications affecting CYP2B6 (the primary enzyme responsible for forming hydroxybupropion) may alter bupropion metabolism 3, 1
Understanding the half-life of bupropion and its metabolites is essential for appropriate dosing, monitoring for drug interactions, and managing treatment discontinuation.